跳至主要内容
临床试验/ACTRN12616001526460
ACTRN12616001526460已完成未知

Investigation of vision and subjective changes when alteringcylindrical power and axis in healthy adults with normal vision

Brien Holden Vision Institute0 个研究点目标入组 20 人开始时间: 2016年11月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Able to read and comprehend English and give informed consent as
  • demonstrated by signing a record of informed consent.
  • -Be at least 18 years old, male or female.
  • -Have at least 0.75D cylindrical power in at least one eye.
  • -Willing to comply with the clinical trial visit schedule as directed by the
  • Investigator.
  • -Have ocular health findings considered to be normal” and which
  • would not prevent the participant from giving accurate visual acuity

排除标准

  • -Any pre-existing ocular irritation, injury or condition (including
  • infection or disease) of the cornea, conjunctiva or eyelids that would
  • affect visual acuity measurements.
  • -Any systemic disease that adversely affects ocular health e.g.
  • diabetes, Graves disease, and auto-immune diseases such as
  • ankylosing spondylitis, multiple sclerosis, Sjogrens syndrome and
  • systemic lupus erythematosus. Conditions such as systemic
  • hypertension and arthritis do not automatically exclude prospective
  • participants.
  • -Use of or a need for concurrent category S3 and above ocular
  • medication at enrolment and/or during the clinical trial.
  • -Use of or a need for any systemic medication or topical medications
  • which may alter normal ocular findings / are known to affect a
  • participant’s ocular health / physiology or visual acuity either in an
  • adverse or beneficial manner at enrolment and/or during the clinical
  • -Eye surgery within 12 weeks immediately prior to enrolment for this
  • -Rigid gas permeable (RGP) or Orthokeratology lens wear within
  • previous 12 months
  • -Previous corneal refractive surgery.
  • -Currently enrolled in another clinical trial.
  • -Pregnancy.

研究者

发起方
Brien Holden Vision Institute

相似试验